Melanoma Clinical Trials
As one of the top U.S. academic medical centers, UT Southwestern takes part in a wide range of clinical trials aimed at improving the outcomes of patients with melanoma and other types of skin cancer.
Trials currently underway at UT Southwestern include:
- A Phase 3 Study of Pembrolizumab + Epacadostat or Placebo in Subjects With Unresectable or Metastatic Melanoma
- Basket Study of Entrectinib (RXDX-101) for the Treatment of Patients With Solid Tumors Harboring NTRK 1/2/3 (Trk A/B/C), ROS1, or ALK Gene Rearrangements (Fusions) (STARTRK-2)
- Nivolumab and Ipilimumab With or Without Sargramostim in Treating Patients With Stage III-IV Melanoma That Cannot Be Removed by Surgery
Our patients have access to a number of clinical trials of promising new treatments not yet available at many other centers. Talk with your doctor to find out if participating in a clinical trial is right for you.